Brief: Bausch Can Block Alvogen From Copying Xifaxan Diarrhea Drug Until 2029-Us Appeals Court
April 11 (Reuters) - Bausch Health Companies Inc
BHC.TO :
* BAUSCH CAN BLOCK ALVOGEN FROM COPYING XIFAXAN DIARRHEA
DRUG
UNTIL 2029-US APPEALS COURT
Further company coverage: BHC.TO
(Reporting By Caroline Humer)
((caroline.humer@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX heads for monthly gain as mining stocks rise, oil retreats
Canada's Bausch Health Q1 revenue rises
Canada's Bausch Health beats Q1 adjusted EPS estimates
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
Canada Stocks: TSX subdued as healthcare, financials drag; energy gains